Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betamethasone versus lavender or peppermint topical formulations for eczema and psoriasis
IRCT20100420003760N4Phase 2Completed
- Sponsor
- Lorestan University of Medical Sciences
- Start
- Jan 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of betamethasone, lavender oil and peppermint oil in atopic dermatitis (AD) and psoriasis (6 arms), sponsored by Lorestan University of Medical Sciences. Primary endpoint: Improvement in severity of symptoms. Started Jan 2017; status: completed.
02
Drugs
betamethasonelavender oilpeppermint oil
03
Conditions
atopic dermatitis (AD)psoriasis
Beyond the preview
Go deeper on IRCT20100420003760N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100420003760N4.